These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 7457287)
21. Effect of different fractions of dialyzable leukocyte extract--transfer factor--on the chemiluminescence of human phagocytes. Sipka S; Schröder I; Brazsnikova NA Allergol Immunopathol (Madr); 1987; 15(3):143-4. PubMed ID: 3661353 [TBL] [Abstract][Full Text] [Related]
22. Transfer factor in diseases of the central nervous system. Graybill JR Adv Neurol; 1974; 6():107-26. PubMed ID: 4614652 [No Abstract] [Full Text] [Related]
23. Effects of transfer factor in patients with advanced cancer. Krown SE; Pinsky CM; Hirshaut Y; Hansen JA; Oettgen HF Isr J Med Sci; 1978 Oct; 14(10):1026-38. PubMed ID: 310813 [TBL] [Abstract][Full Text] [Related]
24. [Successful treatment of Wiscott-Aldrich syndrome with transfer factor]. Endre L; Nékám K; Osváth P; Nagy M; Károly U; Uhl K Orv Hetil; 1979 Sep; 120(39):2361-6. PubMed ID: 392396 [No Abstract] [Full Text] [Related]
26. [Transfer factor. Properties and possible therapeutic applications (author's transl)]. Grob PJ; Reymond JF; Häcki MA; Frey-Wettstein M MMW Munch Med Wochenschr; 1975 Mar; 117(13):517-24. PubMed ID: 805916 [TBL] [Abstract][Full Text] [Related]
27. Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. V. Antigen-specific lymphocyte responsiveness can be initiated by two structurally distinct polyribonucleopeptides. Wilson GB; Paddock GV; Fudenberg HH Thymus; 1981 Feb; 2(4-5):257-6. PubMed ID: 6165106 [TBL] [Abstract][Full Text] [Related]
30. Effects of dialyzable leukocyte extracts (DLE) with transfer factor activity on leukocyte migration in vitro. IV. Two distinct effects of DLE on leukocyte migration can be produced by prostaglandins. Wilson GB; Fudenberg HH; Jonsson HT; Smith CL Clin Immunol Immunopathol; 1980 May; 16(1):90-102. PubMed ID: 7379353 [No Abstract] [Full Text] [Related]
31. Nature and activities of transfer factor. Petersen EA; Kirkpatrick CH Ann N Y Acad Sci; 1979; 332():216-27. PubMed ID: 231399 [No Abstract] [Full Text] [Related]
32. [Transfer factor and its therapeutic use]. Rosenthal M Schweiz Med Wochenschr; 1974 Oct; 104(43):1501-6. PubMed ID: 4549135 [No Abstract] [Full Text] [Related]
33. Application of transfer factor to clinical immunotherapy. Greco RS Surg Gynecol Obstet; 1976 May; 142(5):765-78. PubMed ID: 772850 [No Abstract] [Full Text] [Related]
34. Wiskott-Aldrich syndrome with 18-year survival. Treatment with transfer factor. Sellars WA; South MA Am J Dis Child; 1975 May; 129(5):622-7. PubMed ID: 806224 [TBL] [Abstract][Full Text] [Related]
35. [Discrepancy between the clinical and immunologic picture of in vitro diagnosis during transfer factor therapy in a patient with Wiscott-Aldrich syndrome]. Schütt C; Eggers G; Schröder I; Kruse H; Schulz M; Blau HJ Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):677-84. PubMed ID: 6198251 [TBL] [Abstract][Full Text] [Related]
36. Osteoarticular and chronic mucocutaneous candidiasis. Alarcón GS; Patrucco R; Castillo W Ala J Med Sci; 1982 Oct; 19(4):368-70. PubMed ID: 7181035 [No Abstract] [Full Text] [Related]
37. [Immunomorphological changes in the lymph nodes and spleen of rats sensitized with the transfer factor]. Chivinda Eduardo AB; Kalynovs'ka IH Fiziol Zh (1994); 2000; 46(4):66-70. PubMed ID: 10997302 [TBL] [Abstract][Full Text] [Related]
38. "Discoid" lupus erythematosus: dramatic clinical and immunological response to dialyzable leukocyte extract (transfer factor). Fudenberg HH; Strelkauskas AJ; Goust JM; Osborne D; Fort D; Vasily D Trans Assoc Am Physicians; 1981; 94():279-91. PubMed ID: 6979820 [No Abstract] [Full Text] [Related]